Nanoencapsulation of Nimodipine in Novel Biocompatible Poly(propyleneco-butylene succinate) Aliphatic Copolyesters for Sustained Release

7413's picture
Journal Title, Volume, Page: 
Journal of nanomaterials, Volume 2009, Article ID 716242, 11 pages,
Year of Publication: 
2009
Authors: 
Feras I. Kanaze
Pharmathen S.A., Pharmaceutical Industry, Dervenakion Str 6, Pallini Attikis, 153 51 Attiki, Greece
Current Affiliation: 
Department of Pharmacy,Faculty of Medicine & Health Sciences, An-Najah National University, Nablus, Palestine
Sofia Papadimitriou
Laboratory of Organic Chemical Technology, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, GR-541 24 Macedonia, Greece
George Z. Papageorgiou
Laboratory of Organic Chemical Technology, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, GR-541 24 Macedonia, Greece
Manolis Georgarakis
Section of Pharmaceutics and Drug Control, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 541 24 Macedonia, Greece
Dimitrios N. Bikiaris
Laboratory of Organic Chemical Technology, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, GR-541 24 Macedonia, Greece
Preferred Abstract (Original): 

Biocompatible poly(propylene-co-butylene succinate) (PPBSu) copolyesters, containing up to 50 mol% butylene succinate units, were synthesized by the two-stage melt polycondensation method (esterification and polycondensation). The copolymers were fully characterized and biocompatibility studies were also performed. They were proved to be biocompatible and they were used as polymer matrices for the preparation of drug loaded nanoparticles. Nimodipine was selected as a model hydrophobic poorly water soluble drug. From the results obtained by dynamic light scattering (DLS) and scanning electron microscopy (SEM), drug loaded copolymer nanoparticles were found to exhibit a spherical shape and their mean diameter appeared in the range of 180–200 nm. Fourier Transformation-Infrared Spectroscopy (FTIR) spectra indicated that no chemical interaction between the drug and the matrix could be justified, while Wide-Angle X-Ray Diffraction (WAXD) patterns proved a low degree of crystallinity of Nimodipine in the nanoparticles. The release behavior of the model drug from nanoparticles was also investigated in order to identify modifications and find out any possible correlation between the chemical composition of the polymer matrix and the drug release rates.

AttachmentSize
Nanoencapsulation of Nimodipine in Novel Biocompatible Poly(propyleneco-butylene succinate) Aliphatic Copolyesters for Sustained Release3.24 MB